|
Volumn 7, Issue 2, 2008, Pages 193-208
|
Therapeutic vaccines against IgE-mediated allergies
|
Author keywords
Atopic allergies; Cytokine; Dermatitis; IgE; Therapeutic vaccine
|
Indexed keywords
ALUMINUM POTASSIUM SULFATE;
CYTOKINE;
DNA VACCINE;
IMMUNOGLOBULIN E;
IMMUNOLOGICAL ADJUVANT;
INTERLEUKIN 13;
INTERLEUKIN 18;
INTERLEUKIN 33;
INTERLEUKIN 4;
INTERLEUKIN 4 ANTIBODY;
INTERLEUKIN 5;
INTERLEUKIN 7;
MONOCLONAL ANTIBODY;
MONTANIDE ISA 720;
PHOSPHORYL LIPID A;
UNCLASSIFIED DRUG;
VACCINE;
ALLERGY;
ANTIGEN STRUCTURE;
CLINICAL TRIAL;
DRUG BINDING;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TARGETING;
HUMAN;
IMMUNOGENICITY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
REVIEW;
TH2 CELL;
UNSPECIFIED SIDE EFFECT;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGEN-PRESENTING CELLS;
CYTOKINES;
HUMANS;
HYPERSENSITIVITY, IMMEDIATE;
IMMUNOGLOBULIN E;
IMMUNOTHERAPY;
INTERLEUKINS;
MICE;
RATS;
RECEPTORS, IGE;
VACCINES;
|
EID: 40549089897
PISSN: 14760584
EISSN: 17448395
Source Type: Journal
DOI: 10.1586/14760584.7.2.193 Document Type: Review |
Times cited : (14)
|
References (76)
|